Development of 153Sm-DTPA-rituximab for radioimmunotherapy
Nukleonika, 2009 - infona.pl
Combining beta-particle effect with therapeutic properties of anti-CD20 monoclonal antibody
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …
[PDF][PDF] Development of 153Sm-DTPA-rituximab for radioimmunotherapy
AR Jalilian, H Yousefnia, J Garousi, S Moradkhani - nukleonika.pl
Combining beta-particle effect with therapeutic properties of anti-CD20 monoclonal antibody
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …
Development of {sup 153} Sm-DTPA-rituximab for radioimmunotherapy
A Bahrami-Samani, M Ghannadi-Maragheh… - Nukleonika, 2009 - osti.gov
Combining beta-particle effect with therapeutic properties of anti-CD20 monoclonal antibody
in lymphomas, Mabthera (rituximab) was targeted in this study. The antibody was labeled …
in lymphomas, Mabthera (rituximab) was targeted in this study. The antibody was labeled …
Development of 153Sm-DTPA-rituximab for radioimmunotherapy
A Bahrami-Samani, M Ghannadi-Maragheh… - …, 2009 - yadda.icm.edu.pl
Combining beta-particle effect with therapeutic properties of anti-CD20 monoclonal antibody
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …
[PDF][PDF] Development of 153Sm-DTPA-rituximab for radioimmunotherapy
A Bahrami-Samani, M Ghannadi-Maragheh… - …, 2009 - bibliotekanauki.pl
Combining beta-particle effect with therapeutic properties of anti-CD20 monoclonal antibody
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …
Development of 153Sm-DTPA-rituximab for radioimmunotherapy
A Bahrami-Samani, M Ghannadi-Maragheh… - Nukleonika, 2009 - inis.iaea.org
[en] Combining beta-particle effect with therapeutic properties of anti-CD20 monoclonal
antibody in lymphomas, Mabthera (rituximab) was targeted in this study. The antibody was …
antibody in lymphomas, Mabthera (rituximab) was targeted in this study. The antibody was …
DEVELOPMENT OF 153 Sm-DTPA-RITUXIMAB FOR RADIOIMMUNOTHERAPY
A Bahrami-Samani, M Ghannadi-Maragheh… - NUKLEONIKA, 2009 - nukleonika.pl
Combining beta-particle effect with therapeutic properties of anti-CD20 monoclonal antibody
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …
in lymphomas, Mabthera™(rituximab) was targeted in this study. The antibody was labeled …